Lentinan Combined with (125)I Brachytherapy for Recurrent Ovarian Cancer

Table 6

Comparison of short-term efficacy between the two groups, n (%).

Group	n	CR	PR	SD	PD	RR	DCR
Control group	80	13 (16%)	45 (56%)	2 (3%)	20 (25%)	58 (73%)	60 (75%)
Observation group	80	16 (20%)	48 (60%)	4 (5%)	12 (15%)	64 (80%)	68 (85%)
χ^2	4.312
value	0.026